Zinc oxide and titanium dioxide are the two filters a brand can put on pack and legitimately call a physical block. That short list is the whole reason mineral sunscreen behaves the way it does as a development category. Both particles sit on the skin surface and scatter ultraviolet light instead of absorbing it, and every development headache that follows comes out of that one mechanism.
The headache brands name first is the white cast. It is not a formulation flaw so much as physics doing exactly what it was asked to do: a white pigment that reflects UV also reflects visible light. Anything that reduces the cast is, in practice, a trade against SPF headroom.
Particle size is the lever, and it cuts both ways
Reducing zinc oxide particle size lowers visible whiteness, because smaller particles scatter less of the visible spectrum. Push too far and UVA attenuation drops off, since the longer wavelengths need larger particles to be scattered effectively. A formulator working a brief that says “high protection, no cast, no tint” is being asked to sit on both ends of that curve at once.
The practical routes out are dispersion quality, surface treatment of the particle, and the vehicle itself. Coated grades disperse better and resist agglomeration, which is often what people are actually seeing when a sample looks chalky an hour after application rather than at the moment of rubbing in. Oil phase selection changes the refractive index mismatch and does more for perceived whiteness than most brands expect.
None of this is free. Higher-grade dispersions cost more per kilo, and the difference shows up in landed cost at a level that matters for anything selling under about fifteen dollars retail. That trade should be decided at the brief stage, not discovered at the second sample round.
Four formats, four genuinely different projects
Brands tend to arrive asking for a mineral sunscreen as though format were a packaging decision made later. It isn’t. Each of the common formats changes the base, the filter loading, and the testing plan.
- Fluid serum textures — the hardest brief. Low viscosity works against keeping heavy inorganic particles suspended, so stability testing needs to run longer and settle time on shelf becomes a real complaint driver.
- Sticks — anhydrous, wax-structured, and forgiving on preservation because there’s no water phase to protect. The catch is application weight: consumers apply far less from a stick than the amount used in SPF testing, which is a labelling and education problem rather than a lab one.
- Water-resistant sport formats — film formers do the work here, and the claim has to be earned through the specific water-resistance protocol for the target market, not asserted.
- Tinted — iron oxides added for tone correction also contribute meaningfully to visible-light and blue-light attenuation, which is a genuine functional benefit and one of the few places where the cosmetic fix and the protective function point the same direction.
The tinted route is where a lot of the category has quietly moved, because it converts the white cast from a defect into a shade proposition. It also imports a shade-range obligation. A tinted product launching with three shades reads as unfinished to buyers in markets with wide skin tone diversity, and that objection now comes up in vetting rather than after launch.
Classification decides your timeline before formulation does
Sun protection is regulated inconsistently across export markets, and the classification determines how long the project takes far more than the formula does.
In the United States, sunscreens sit under an FDA over-the-counter drug framework. In the European Union they are cosmetics. Korea treats them as functional cosmetics under the Ministry of Food and Drug Safety. Japan handles them as quasi-drugs. Australia routes them through the Therapeutic Goods Administration. Canada has its own split, where a product can land as a drug or a natural health product depending on the filters used.
A brand planning simultaneous launches across three of those markets is running three different dossiers, not one. Filter grades that are acceptable in one jurisdiction may need a different justification in another, and SPF testing accepted in one market is not automatically portable. The sequencing question — which market first, and does the first formula have to survive the others — belongs in the first conversation with a manufacturer.
The environmental claim has tightened
“Reef safe” has no regulatory definition anywhere. It grew out of restrictions on specific organic filters — Hawaii and Palau both moved against oxybenzone and octinoxate — and then drifted into general use as a halo term for any mineral sunscreen.
Buyers have caught up with that. The questions now are narrower: which filters, at what grade, with what supporting documentation. A brand that can hand over a full ingredient rationale moves through vetting quickly. One relying on the phrase alone increasingly gets asked to substantiate it, and the answer “it’s mineral” is no longer sufficient on its own.
The same tightening applies to “natural.” Both filters here are inorganic materials that are processed, coated, and milled to spec. Positioning them as untouched minerals invites a challenge that costs more to answer than it would have cost to write the claim accurately in the first place.
“The briefs we see for this category have changed shape. Two years ago the request was usually a single SPF product with no white cast; now brands come in with a format decision already made and questions about which market they can launch in first without redoing the whole dossier. Buyers are also much more pointed about environmental language than they were — the ones who’ve been burned by a claim challenge ask for ingredient documentation before they ask for a price. Brands that arrive with their target market and their claim set decided tend to get through development in a fraction of the time.” — Hyejin Cho, Digital Marketing Specialist, Marketing and Communication Team at SPSCOS
What a workable brief contains
Four decisions, made up front, remove most of the sample churn in this category.
Name the first launch market and accept that it sets the regulatory path. A formula built for a cosmetic framework and later pushed toward a drug framework usually needs rework, and the rework lands at the worst point in the calendar.
State the cast tolerance in plain terms rather than as an absolute. “Acceptable on medium-deep skin under daylight” is a brief a formulator can work to. “Zero white cast at SPF 50” is a wish, and pretending otherwise wastes a sample round.
Decide tinted or untinted before texture, because the two paths diverge immediately at the pigment stage.
And set the claim list early, since water resistance, blue-light language, and any environmental positioning each pull in testing or documentation that has its own lead time. Korean manufacturers building for export markets in the Gulf and Southeast Asia have found that the texture expectations in hot, humid climates narrow the workable formula space further, which is another reason to fix the destination before the first bench sample.